(Q33382749)
Statements
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma (English)
Melanie B Thomas
Jeffrey S Morris
Michiko Iwasaki
E Lin
Ahmed Kaseb
Katrina Glover
Marta Davila
James Abbruzzese